<?xml version="1.0" encoding="UTF-8"?>
<p>Sample size and randomisation: The sample (n=130) will be randomised 1:1 to valacyclovir or placebo with the randomisation sequences balanced in blocks of random size (2, 4) to reduce the likelihood of clinicians guessing the next patientâ€™s treatment.</p>
